Powered by

Kala Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results

Mar 26, 2018 - Business Wire

Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of product candidates using its proprietary mucus-penetrating particle (MPP) technology, today reported financial results for the fourth quarter and full year 2017.

"This last year included significant accomplishments for Kala, marked by a successful initial public offering, and the acceptance of a New Drug Application for INVELTYSTM (KPI-121 1%) for the treatment of infla...